ELGX Says It Completed Patient Enrollment in Ovation LUCY Study


Endologix, Inc. developer and marketer of innovative treatments for aortic disorders, announced that it has completed patient enrollment in the LUCY (Evaluation of FemaLes who are Underrepresented Candidates for Abdominal Aortic AneurYsm Repair) study, a multi-center post-market registry designed to explore the clinical benefits associated with endovascular aneurysm repair (EVAR) using the Ovation(R) Abdominal Stent Graft Platform in femal patients with AAA, as compared to males.

Dr. Ash and the Lucy study, currently available at Christie Clinic, were featured in this online article.